: "arise: a phase 3 randomized trial of erenumab for episodic migraine.".ai-based software may help predict risk of dementia...#1 in news, talk, and sports in los angeles and orange county.
shocking figures uncovered by labour show some patients are suffering agonising waits of as many as 541 days to begin treatment.